Stevanato Group

🌍 The customer is the energy that moves our world! As we look back on a year full of challenges, successes, and meaningful connections we want to thank our clients and partners for their valuable support. With Christmas just around the corner, it’s now time to enjoy precious moments with our loved ones. Let’s rest and recharge, to be ready to embark on an even more exciting journey together in 2025! ✨From all of us at Stevanato Group, a joyful holiday season and a wonderful New Year. #StevanatoGroup #SeasonsGreetings #IntegratedSolutionsProvider

Discover our semi-automatic benchtop unit, designed to support you from the early stage of your development or assembly process. This unit is part of our platform, which allows for a smooth technology transfer and production ramp-up, from benchtop to a fully automatic machine for your commercial production. Our benchtop stands out for its flexibility since it allows you to process many different types of auto-injectors available on the market. One of the devices compatible with this versatile benchtop unit is Aidaptus®, a two-step, single-use auto-injector, which accommodates both 1mL and 2.25 mL pre-filled glass syringes in the same form factor. Watch the video for an in-depth look 👇 https://lnkd.in/dTsr59MG #StevanatoGroup #Benchtop #Assembly #Aidaptus #Autoinjector #IntegratedSolutionsProvider

✨ We are honored to have received, for the second consecutive year, the Certificate of Resilience from Biocon Biologics during their Symposia 2024 – Annual Supplier Conference, which recognizes our resilience in ensuring supply continuity, even under adverse conditions. The event brought together Biocon's leading industry professionals, key suppliers and thought leaders where we were pleased to participate in the panel discussion on “Circular Economy & Biopharma SCM,” emphasizing our commitment to ESG and Circular Economy initiatives while presenting our innovative solutions in this area. Alessandro Orlando Vinayak Joshi Rajesh Kethineedi Hari Rachamala #StevanatoGroup #IntegratedSolutionsProvider #Resilience

▶️ Our webinar ‘Tailoring GLP-1 Biosimilar Delivery Systems for the Expanding Obesity Market’ is now available on-demand! Don't miss the opportunity to gain valuable insights from our experts Tommaso Borghi, Manuela Giacon, and Sara Silvagni as they explore innovative solutions that meet the design and industrial challenges of GLP-1 biosimilar delivery systems. You can follow the webinar on-demand here: https://lnkd.in/dbfAuUBz #StevanatoGroup #GLP1 #Biosimilars #DeliverySystems #IntegratedSolutionsProvider

❄️ The mechanical and Container Closure Integrity (CCI) performance of our 2R Fina® glass vials have been successfully tested under various conditions, proving their suitability at very low temperatures over a storage period of 24 months. In our article, we present a comprehensive study demonstrating their suitability for storing sensitive molecules under deep cold conditions. Interested to know more? Read the full article here: https://lnkd.in/dTSgQnGR #StevanatoGroup #IntegratedSolutionsProvider #DeepColdStorage #2RFinaVials

🌟 Are you looking for a reliable, high-speed unit for inspecting your challenging high-value drugs? Discover our CVT Core Inspection machine for syringes, designed to process your valuable drugs at high speed. Key features include: ✅ Denesting, inspection, and renesting all in a single machine with a compact footprint; ✅ Recipe-controlled spinning schedule for even more precise and accurate inspection; ✅ Flexibility and speed combined to support your production. Learn more about how our CVT Core unit is the ultimate choice to meet the challenges in high-value drug inspection: https://lnkd.in/dkyNd_sU #StevanatoGroup #CVTcore #Syringes #InspectionMachine #IntegratedSolutionsProvider

🔎Not sure if your primary container has adequate Container Closure Integrity (CCI)? Stevanato Group’s US Technology Excellence Center can help you navigate the multitude of tests in USP <1207> to determine your drug container’s inherent package integrity, down to the maximum allowable leak limit (MALL) for microbial ingress. Demonstrate the CCI of your finished primary container by using our state-of-the-art deterministic Helium-leak method to keep your drug safe and effective today! 👉 Discover more: https://lnkd.in/d2ZYcUn5 #StevanatoGroup #CCIT #SterileBarrier #HeliumLeak #AnalyticalServices #Deterministic #MALL

Looking for the right partner for your vaccine manufacturing needs? The vaccine landscape is evolving rapidly, driven by innovative technologies such as mRNA, recombinant, viral vector, and combination vaccines. Stevanato Group can serve vaccine production processes with comprehensive solutions covering the full pharma value chain. Our unique position in the market enables us to be an integrated provider of analytical services, primary packaging, inspection and packaging equipment. ⏩ Discover our solutions, ideal for high-speed, high-volume production: https://lnkd.in/enV_bQVb #StevanatoGroup #Vaccines #IntegratedSolutionsProvider

What are the essential requirements of primary packaging for complex drugs? As drug formulations evolve, cosmetic appearance and mechanical resistance are no longer a nice to have—they're a necessity. That’s why Stevanato Group developed Nexa® Vials, designed to offer top-tier quality and safety for the most demanding drugs. Discover more: https://lnkd.in/drME6jWv #StevanatoGroup #PharmaPackaging #Innovation #NexaVials

📅 Only two days left until our webinar, “Tailoring GLP-1 Biosimilar Delivery Systems for the Expanding Obesity Market”. Join this insightful session with our experts Tommaso Borghi, Manuela Giacon and Sara Silvagni as we delve into how our solutions can support the design and industrialization of GLP-1 biosimilar delivery systems. Don’t miss it out! You can register until tomorrow at 2:00 PM (CET): https://lnkd.in/eDa8iKKv #StevanatoGroup #GLP1 #Biosimilars #DeliverySystems #IntegratedSolutionsProvider #Webinar